This bill creates tax incentives for New Jersey residents with disabilities to save for disability-related expenses through ABLE accounts. It provides a one-time $750 dollar-for-dollar matching grant for initial deposits into a New Jersey ABLE account (for taxpayers earning $150,000 or less annually) and allows a state tax deduction for all contributions to these accounts. The matching funds are subject to annual state budget approval, with the Department of Human Services determining allocation if funding is insufficient. The program expands New Jersey’s existing ABLE program, which allows tax-advantaged savings for expenses like housing, education, and assistive technology, without affecting Medicaid eligibility.
This bill (A3126) amends New Jersey law to provide disability insurance coverage for members of the Teachers’ Pension and Annuity Fund (TPAF) and Public Employees’ Retirement System (PERS) who become disabled. It replaces previous disability retirement allowances with group insurance coverage, funded through a special "Teachers Group Disability Insurance Premium Fund" paid by employers. The policy provides a monthly benefit equal to 60% of a member’s base salary (minimum $50) for total disability starting before age 60, covering up to age 70, while excluding pregnancy, war injuries, and self-inflicted harm. The bill was withdrawn on January 13, 2026, as it was already enacted as P.L.2025, c.370.
This bill increases Medicaid reimbursement rates for in-person partial care and intensive outpatient behavioral health and substance use disorder (SUD) treatment services for adults aged 21+ by 35%. It also sets a minimum $10 per one-way trip reimbursement for transportation to these services (up from $7), covering both transportation and mileage costs. The changes apply to all Medicaid providers - both fee-for-service and managed care systems - effective after the bill's enactment date. These rate adjustments directly affect adult Medicaid beneficiaries receiving these services and the outpatient facilities delivering them.
This bill requires New Jersey long-term care facilities (including nursing homes and assisted living residences) to meet with each resident at least once yearly to verify if their "proxy directive" (a document naming someone to make decisions if they lose capacity) remains accurate and current. It directly affects residents in these facilities and the facilities themselves, which must implement this annual review process. The bill does not compel residents to create or maintain a proxy directive, only to check existing ones. This ensures residents' designated decision-makers stay aligned with their current wishes.
This bill, if enacted, would require New Jersey's Department of Health to provide Haitian migrants in the state with free access to a range of contraceptives - including intrauterine devices, birth control pills, and Depo-Provera injections - through partnerships with community health clinics and migrant support organizations. It mandates that services include comprehensive reproductive health education and counseling to support informed choices. The Department must develop implementation guidelines within 120 days and submit annual reports detailing outreach efforts, usage statistics, and any barriers Haitian migrants face in accessing these services. The law directly affects Haitian migrants residing in New Jersey by removing cost barriers to specific contraceptive options.
This bill (A 3181) prohibits using cadaveric fetal tissue obtained from elective abortions for any research and bans using any cadaveric fetal tissue to research cosmetic treatments. It specifically allows research using tissue from miscarriages or stillbirths but does not affect existing bans on buying or selling fetal tissue. The bill also requires physicians treating infertility patients to provide written information about embryo disposition options and document patient acknowledgment in medical records. These changes apply to research institutions and healthcare providers in New Jersey conducting such studies.
This bill requires New Jersey health insurance carriers to meet new standards ensuring policyholders have reasonable and timely access to specific physician specialists at in-network hospitals. It mandates regulations covering access to anesthesiologists, radiologists, pathologists, emergency medicine physicians, and their supervised services. The rules, to be developed by the Commissioner of Banking and Insurance, will address network adequacy regarding specialist availability, geographic coverage, and in-network access. These requirements apply directly to health insurance companies offering managed care plans in New Jersey.
This bill amends New Jersey's cannabis regulations to streamline licensing for medical cannabis businesses. It requires the Cannabis Regulatory Commission to begin processing new cultivator, manufacturer, and dispensary permit applications within 90 days, while ensuring the first three alternative treatment centers (ATCs) are distributed across northern, central, and southern regions. The bill establishes "conditional permits" for at least one-third of all medical cannabis licenses, with requirements including income limits ($200,000 individual/$400,000 joint), background checks, and proof of local residency for key personnel. It also sets nonrefundable application fees and mandates a 90-day review timeline for permit applications. These changes directly affect new and existing medical cannabis businesses seeking licenses to operate in New Jersey.
This New Jersey Assembly Resolution (AR 49) urges Congress to fully fund existing programs authorized under the federal Elder Justice Act of 2010. It specifically requests funding for state adult protective services, long-term care ombudsman programs, facility survey agencies, forensic centers, and the Elder Justice Advisory Board - programs Congress has not fully funded since 2014, per a 2020 Congressional Research Service report. The resolution does not create new law but formally requests Congress restore funding to these elder abuse prevention and response initiatives.
This bill (A 626) requires New Jersey Medicaid to cover substance use disorder treatment services provided by community-based organizations. It mandates opioid treatment programs to offer harm reduction services and individualized counseling schedules, while prohibiting discharges for refusing counseling or missing doses (unless overdose risk is imminent). The bill also establishes new licensing standards for community organizations seeking Medicaid reimbursement and defines key terms like "medication units" for opioid treatment delivery. These changes directly affect Medicaid recipients, opioid treatment programs, and community-based service providers across New Jersey.
